Canada Pension Plan Investment Board
CSTL icon

Canada Pension Plan Investment Board’s Castle Biosciences CSTL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,400
Closed -$280K – 1737
2026
Q1 		$280K Buy
11,400
+5,100
+81% +$167K ﹤0.01% 1442
2025
Q4 		$245K Buy
6,300
+3,900
+163% +$126K ﹤0.01% 1584
2025
Q3 		$54.6K Buy
+2,400
New +$48.8K ﹤0.01% 1244
2025
Q2 		– Sell
-2,400
Closed -$48K – 1374
2025
Q1 		$48K Buy
2,400
+1,500
+167% +$37.1K ﹤0.01% 1206
2024
Q4 		$24K Buy
+900
New +$27.4K ﹤0.01% 1355

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's CSTL Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Castle Biosciences (CSTL) in Q2 2026, closing a stake of 11,400 shares — an estimated $280K sold.

Canada Pension Plan Investment Board first reported a position in CSTL in Q4 2024 and held it in 5 quarters. The position peaked at $280K in Q1 2026. 176 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Castle Biosciences position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 11,400 Castle Biosciences shares in Q2 2026, an estimated $280K.
  • Canada Pension Plan Investment Board first reported a position in Castle Biosciences in Q4 2024 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's Castle Biosciences position peaked at $280K in Q1 2026.
  • 176 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.